0002066303-26-000001.txt : 20260123 0002066303-26-000001.hdr.sgml : 20260123 20260123135308 ACCESSION NUMBER: 0002066303-26-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260123 DATE AS OF CHANGE: 20260123 EFFECTIVENESS DATE: 20260123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mivax Therapeutics, Inc. CENTRAL INDEX KEY: 0002066303 ORGANIZATION NAME: EIN: 990726699 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-544963 FILM NUMBER: 26555552 BUSINESS ADDRESS: STREET 1: 701 CHINA BASIN ST STREET 2: APT 605 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 7857706160 MAIL ADDRESS: STREET 1: 701 CHINA BASIN ST STREET 2: APT 605 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D/A 1 primary_doc.xml X0708 D/A LIVE 0002066303 Mivax Therapeutics, Inc. 701 CHINA BASIN ST APT 605 SAN FRANCISCO CA CALIFORNIA 94158 7857706160 DELAWARE None None Corporation true 2024 Viraj Balkrishna Deshpande 701 China Basin St Apt 605 San Francisco CA CALIFORNIA 94158 Executive Officer President and Secretary Pragyesh Dhungel 556 Wisconsin St San Francisco CA CALIFORNIA 94107 Executive Officer Chief Executive Officer and Treasurer Biotechnology $1 - $1,000,000 06b true 0002066303-25-000002 2025-04-17 false true false 2000 500000 107500 392500 Some or all of non-U.S. investors were offered securities under Reg S and are excluded from Reg D reporting. true 10 21 0 0 0 false Mivax Therapeutics, Inc. Viraj Balkrishna Deshpande Viraj Balkrishna Deshpande President 2026-01-23